Correlation Between Norman Broadbent and Tissue Regenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Norman Broadbent and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Norman Broadbent and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Norman Broadbent Plc and Tissue Regenix Group, you can compare the effects of market volatilities on Norman Broadbent and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Norman Broadbent with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Norman Broadbent and Tissue Regenix.

Diversification Opportunities for Norman Broadbent and Tissue Regenix

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Norman and Tissue is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Norman Broadbent Plc and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and Norman Broadbent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Norman Broadbent Plc are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of Norman Broadbent i.e., Norman Broadbent and Tissue Regenix go up and down completely randomly.

Pair Corralation between Norman Broadbent and Tissue Regenix

Assuming the 90 days trading horizon Norman Broadbent Plc is expected to under-perform the Tissue Regenix. In addition to that, Norman Broadbent is 1.83 times more volatile than Tissue Regenix Group. It trades about -0.44 of its total potential returns per unit of risk. Tissue Regenix Group is currently generating about 0.08 per unit of volatility. If you would invest  5,700  in Tissue Regenix Group on October 10, 2024 and sell it today you would earn a total of  150.00  from holding Tissue Regenix Group or generate 2.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Norman Broadbent Plc  vs.  Tissue Regenix Group

 Performance 
       Timeline  
Norman Broadbent Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Norman Broadbent Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Tissue Regenix Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Norman Broadbent and Tissue Regenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Norman Broadbent and Tissue Regenix

The main advantage of trading using opposite Norman Broadbent and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Norman Broadbent position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.
The idea behind Norman Broadbent Plc and Tissue Regenix Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies